DXSP DXS International Plc

 
TIDMDXSP 
 
 
 
 
 
   DXS INTERNATIONAL PLC 
 
   Notification of Significant Shareholding and 
 
   PDMR Dealing 
 
   The Board of DXS International plc (the "Company"), the NEX quoted 
clinical decision support developer and supplier of clinical decision 
support systems is pleased to confirm changes to the significant 
shareholdings in the Company. 
 
   Following admission of the Placing Shares and the Subscription Shares 
(the "New Ordinary Shares"), on 26th February the Company's enlarged 
issued share capital now comprises 48,256,416 Ordinary Shares of 0.33p 
pence each with voting rights in the Company. This figure may be used by 
shareholders in the Company as the denominator for the calculations by 
which they will determine if they are required to notify their interest 
in, or a change in the interest in, the share capital of the Company 
under the FCA's Disclosure and Transparency Rules. 
 
   The Company has received notification from the following persons that 
they have acquired Significant Shareholdings in the Company through 
their participation in the Placing: 
 
 
 
 
                                                        Per cent 
                      Transaction     No. of Voting     of voting    Date of      Date of 
Name of Person         type          Rights Resulting    rights    Acquisition  Notification 
--------------------  ------------  -----------------  ----------  -----------  ------------ 
Bank Of New York 
 /Nominees/ Ltd       Acquisition           1,775,000       3.68%    26 Feb 20   26 Feb 2020 
--------------------  ------------  -----------------  ----------  -----------  ------------ 
Octopus Investments 
 Nominees Limited     Acquisition           6,250,000      12.95%    26 Feb 20   27 Feb 2020 
--------------------  ------------  -----------------  ----------  -----------  ------------ 
 
 
   The Company is also pleased to confirm that pursuant to the Placing and 
Subscription Mr Immelman's interests, including those of persons closely 
associated with him, have increased by reason of a subscription for 
125,000 New Ordinary Shares and now total 4,875,501 Ordinary Shares 
representing 10.10% of the issued share capital of the Company. 
 
 
 
 
     Details of the person discharging managerial responsibilities 
1     / person closely associated 
---  ------------------------------------------------------------------------- 
                                    DL Services Limited, a company owned 
a)   Name                            and controlled by Lorraine Immelman 
---  -----------------------------  ------------------------------------------ 
2    Reason for the notification 
---  ------------------------------------------------------------------------- 
                                    Person closely associated with Chief 
a)   Position/status                 Executive Officer David Immelman 
---  -----------------------------  ------------------------------------------ 
     Initial notification 
b)    /Amendment                    Initial 
---  -----------------------------  ------------------------------------------ 
     Details of the issuer, emission allowance market participant, 
3     auction platform, auctioneer or auction monitor 
---  ------------------------------------------------------------------------- 
a)   Name                           DXS INTERNATIONAL PLC 
---  -----------------------------  ------------------------------------------ 
b)   LEI                            2138001R1KEUWTXEVJ44 
---  -----------------------------  ------------------------------------------ 
     Details of the transaction(s): section to be repeated for 
      (i) each type of instrument; (ii) each type of transaction; 
      (iii) each date; and (iv) each place where transactions 
4     have been conducted 
---  ------------------------------------------------------------------------- 
     Description of the financial 
      instrument, type of 
a)    instrument                    Ordinary Shares of 0.33p each 
--- 
 
     Identification code            ISIN GB00B2Q6HZ92 
 
b)   Nature of the transaction      Subscription 
---  -----------------------------  ------------------------------------------ 
c)   Price(s) and volume(s) 
--- 
                                     Price(s)                 Volume(s) 
---                                  -------------------  ------------------ 
   8p                                                                125,000 
   -----------------------------------------------------  ------------------ 
 
d)   Aggregated information 
--- 
 
 - Aggregated volume 
 
 - Price 
 
e)   Date of the transaction        26 February 2020 
---  -----------------------------  ------------------------------------------ 
f)   Place of the transaction       Outside a trading venue 
---  -----------------------------  ------------------------------------------ 
 
 
   The Directors of DXS International plc accept responsibility for this 
announcement 
 
   Enquiries: 
 
 
 
 
David Immelman (Chief Executive)               01252 719800 
 DXS International plc                david@dxs-systems.com 
Wrecclesham House 
 Wrecclesham Road 
 Farnham 
 Surrey 
 GU10 4PS 
www.dxs-systems.co.uk 
 
 
 
 
 
 
 
 
Corporate Advisor 
David Papworth 
 City & Merchant    0207 101 7676 
 
 
 
 
 
 
 
 
Corporate Broker 
Hybridan LLP 
 Claire Louise Noyce   020 3764 2341 
 
 
   Note to Editors: 
 
   DXS International presents up to date treatment guidelines and 
recommendations, from Clinical Commissioning Groups and other trusted 
NHS sources, to doctors, nurses and pharmacists in their workflow and 
during the patient consultation. This effective clinical decision 
support ultimately translates to improved healthcare outcomes delivered 
more cost effectively which should significantly contribute towards the 
NHS achieving its projected efficiency savings. 
 
 
 
 
 
 
 
 
 
 

(END) Dow Jones Newswires

February 28, 2020 07:00 ET (12:00 GMT)

DXS (AQSE:DXSP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

DXS (AQSE:DXSP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024